Quince Therapeutics, Inc.QNCXNASDAQ
Loading
Enterprise value to EBITDA ratio
Percentile
P71
Within normal range
vs 2Y Ago
-5.6x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | -2.49 | -107.4% |
| 2023 | -1.20 | -368.4% |
| 2022 | 0.45 | +113.1% |
| 2021 | -3.41 | +64.0% |
| 2020 | -9.47 | +63.7% |
| 2019 | -26.10 | +54.0% |
| 2018 | -56.67 | +17.4% |
| 2017 | -68.63 | - |